WORLD-GOVERNMENT-SUMMIT
8.3.2021 13:24:06 CET | Business Wire | Press release
The World Government Summit Dialogues will deliver 21 predictions for the future social, economic, and political order, between 9 – 10 March.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210308005451/en/
The virtual event will host political and industry leaders from around the world, who will each offer their outlooks on the future of vital sectors including healthcare, space, cryptocurrency and more.
Day one will open with a keynote from His Excellency Mohammad Abdullah Al Gergawi, the UAE’s Minister of Cabinet Affairs and Chairman of the World Government Summit Organization, on the priorities for governments in 2021, as they look to navigate the global recovery from the coronavirus (COVID-19) pandemic.
Sessions on day one will focus on the future of Africa, the future of Asia, the future economic order, cryptocurrency and the decentralisation of finance. They will feature Tony Elumelu, Chairman of Heirs Holdings, the United Bank for Africa, Nandan Nilekani, Co-founder of Infosys, Professor Daniel Kahneman, Economics Nobel Prize winner, Anthony Di Iorio, Co-Founder of Ethereum and Jutta Steiner, Co-founder CEO of Parity Technologies, among others.
Day two will open with a keynote address from Dr. Tedros Ghebreyesus, Director-General of the World Health Organization (WHO) where he will outline the future of global public health.
That will be followed by the high-level discussion, “Will the Earth’s Population Be Vaccinated by 2021?”, where His Excellency Macky Sall, President of Senegal, will be joined by Henrietta Fore, Executive Director, UNICEF, His Excellency Sultan Ahmed Bin Sulayem, Group Chairman and CEO, DP World and Dr. David Nabarro, Special Envoy on Covid-19 to the WHO.
A highlight of the second day will see Astrophysicist, Dr. Neil deGrasse Tyson in conversation with the Right Honourable Lord Martin Rees, Astrophysicist, Cosmologist and 60th President of the Royal Society, as they discuss how public-private partnerships can inspire a new generation of STEM enthusiasts to lead the space race and the quest to understand life beyond Earth.
For the full agenda and list of speakers, visit: https://www.worldgovernmentsummit.org/
To register for the event, visit: https://www.worldgovernmentsummit.org/event-registrations/
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005451/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom